In this two-part series, Judy Guzman-Cottrill, DO, Professor of Pediatrics, Division of Infectious Diseases at Oregon Health and Science University, and John Brooks, MD,  former CDC medical officer and epidemiologist, join Mati Hlatshwayo Davis, MD, MPH, FIDSA, to discuss the real-time consequences of federal funding cuts on public health. From dismantled community partnerships to stalled clinical trials, the three examine how these decisions are reshaping pandemic preparedness, and what we risk losing next.

The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be future leaders. Crafted specifically by and for specialists in infectious diseases and HIV, the Leadership Institute offers two tailored leadership development pathways.

Learn More

ID physicians Priya Nori, MD, FSHEA, FIDSA, and Gonzalo Bearman, MD, MPH, FACP, FSHEA, FIDSA, join Paul Sax, MD, FIDSA, to discuss challenges often faced by ID specialists, including gaslighting and uncompensated labor. The three discuss how physicians can advocate for themselves, set boundaries, and push for meaningful change within their institutions.

Are We Being Gaslit? A Primer for Recognizing Corporate Jargon to Overcome Gaslighting for the Infectious Disease Workforce: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaf097/8056053

Minimizing Low-Value, Uncompensated Work in Academic Infectious Diseases: A 6-Step Program: https://academic.oup.com/cid/article/78/6/1656/7610959

Infectious diseases fellow Sam Peterson, MD, shares her unique journey to ID with Buddy Creech, MD, MPH, FPIDS. The two explore the power of mentorship, the value of storytelling, and what it takes to inspire the next generation of ID specialists. 

John Fangman, MD, discusses threats to the Affordable Care Act and how they could impact people with HIV with JoAnn Volk, MA, research professor, founder, and co-director of the Center on Health Insurance Reforms at Georgetown University’s McCourt School of Public Policy and Tim Horn, Director, Medication Access at NASTAD. 

Paul Sax, MD, FIDSA, is joined by infectious diseases physicians and international medical graduates, Vidya Sundareshan, MD, and Alfredo Mena Lora, MD, FIDSA, to discuss how international medical graduates (IMGs) can pursue a career in infectious diseases. The trio discuss visa options, job search strategies, and how political change could impact the process.

Paul Sax, MD, FIDSA, speaks with Adam Ratner, MD, MPH, Professor of Pediatrics and Microbiology at NYU Grossman School of Medicine and Director of the Division of Pediatric Infectious Diseases at Hassenfeld Children’s Hospital and Bellevue Hospital Center, about his book, "Booster Shots: The Urgent Lessons of Measles" and the rise of vaccine preventable diseases. 

Anna Person, MD discusses threats to the Medicaid program and how they could impact people with HIV with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Amy Killelea, JD, Assistant Research Professor at the Georgetown University Center on Health Insurance Reforms (CHIR) and consultant to the HIV Medicine Association.  

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, discusses public health forecasting and response efforts with Lior Rennert, PhD, director of the Center for Public Health Modeling and Response at Clemson University, and Dylan George, PhD, director of CDC’s Center for Forecasting and Outbreak Analytics (CFA). 

IDSA Board Member Mati Hlatshwayo Davis, MD, MPH, FIDSA, Former CDC Director Rochelle Walensky, MD, MPH, FIDSA, and VP of Health Programs at the Carter Center, Kashef Ijaz, MD, MPH, discuss the legacy of Former President Jimmy Carter, his work addressing neglected tropical diseases and the impact and value of public advocacy and political support for these diseases. 

Paul Sax, MD, FIDSA, is joined by Varun Phadke, MD, and Daniel Minter, MD, co-creators of CID's new series, "Clinical Dilemmas in Infectious Diseases," which guides readers through challenging clinical management decisions in infectious diseases.

Click here to learn more about submitting to the Clinical Dilemmas in Infectious Diseases series.

Click here to read the first Clinical Dilemmas in Infectious Diseases papers.